@article{51c9118d29914685bf0af92e3635eb49,
title = "Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children{\textquoteright}s Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems",
abstract = "Introduction: Automated insulin delivery (AID) systems can enable improved glycaemic outcomes with reduced mental burden. Open-source AID (OS-AID) systems overcome some of the developmental and access barriers enabling a wider use of these systems. Limited data are available on healthcare professional (HCP) opinions and current practice regarding these systems. The aim of this survey was to gain insight into HCP perceptions and practices around OS-AID. Methods: This survey was developed collaboratively with OS-AID users and distributed to adult and children{\textquoteright}s teams, using an online survey tool. Results were received between February and April 2019. Responses were assessed using simple descriptive statistics with analyses stratified by respondent characteristics. Results: 317 responses were obtained from a range of HCPs in both adult and paediatric services. Key results include: HCP perception of OS-AID as “risky in the wrong hands” (43%); 91% felt uncomfortable initiating discussions around OS-AID because of lack of regulation (67%) and/or their own lack of knowledge (63%). Half of HCPs (47%) reported that they would choose OS-AID if they themselves had type 1 diabetes. Conclusions: HCPs are generally supportive of OS-AID users but many feel uncomfortable with the technicalities of the systems given the lack of approval. Knowledge around the use of these systems was limited. Re-assessment of HCP perceptions should be performed in the future given the evolving landscape of diabetes technology, recent consensus statements and emerging ethical and legal perspectives.",
keywords = "Attitudes, Ethics, Healthcare professional opinion, Open-source automated insulin delivery, Technology",
author = "Crabtree, {Thomas S.J.} and Pratik Choudhary and Alistair Lumb and Peter Hammond and A. McLay and Fiona Campbell and Ng, {Sze M.} and Wilmot, {Emma G.} and Sufyan Hussain",
note = "Funding Information: Thomas S. J. Crabtree has received honoraria/speaker fees and/or educational grants from Novo Nordisk, Sanofi Aventis and Abbott Diabetes Care. Pratik Choudhary has received personal fees from Medtronic, Dexcom, Abbott Diabetes Care, Insulet, Novo Nordisk, Sanofi and Lilly. Sufyan Hussain has received an honorarium for non-promotional educational work from Novo Nordisk. Alistair Lumb has received payments for speaking and advisory boards from Insulet, Dexcom, Abbott Diabetes Care, Novo Nordisk, Sanofi and Institutional Research Support from Abbott Diabetes Care, Novo Nordisk. Fiona Campbell has received honoraria and unrestricted educational grants from Abbott, Novodisk, Eli Lilly, Medtronic, Insulet and Dexcom. Emma G. Wilmot has received personal fees from Abbott Diabetes Care, Dexcom, Eli Lilly, Insulet, Medtronic, Novo Nordisk, Sanofi Aventis. Peter Hammond has received personal fees from Abbott Diabetes Care, Dexcom, Eli Lilly, Insulet, Medtronic, Novo Nordisk, Sanofi Aventis, Glooko/Diasend. Sze M. Ng has nothing to disclose. A McLay is a user of artificial pancreas systems and has received personal fees from Eli Lilly and Novo Nordisk. Funding Information: The authors thank the healthcare professionals who responded to the survey. No funding or sponsorship was received for this study or publication of this article. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. All authors contributed to the development of the questionnaire and were involved in planning the distribution. Processing of results and analysis was performed by TSJ Crabtree, A McLay and EG Wilmot. Further analysis, write-up and editing of the manuscript was performed by TSJ Crabtree with editorial feedback from all authors. A short summary of this work was presented in a correspondence piece in The Lancet Diabetes & Endocrinology. Crabtree et al. [5 ]. Thomas S. J. Crabtree has received honoraria/speaker fees and/or educational grants from Novo Nordisk, Sanofi Aventis and Abbott Diabetes Care. Pratik Choudhary has received personal fees from Medtronic, Dexcom, Abbott Diabetes Care, Insulet, Novo Nordisk, Sanofi and Lilly. Sufyan Hussain has received an honorarium for non-promotional educational work from Novo Nordisk. Alistair Lumb has received payments for speaking and advisory boards from Insulet, Dexcom, Abbott Diabetes Care, Novo Nordisk, Sanofi and Institutional Research Support from Abbott Diabetes Care, Novo Nordisk. Fiona Campbell has received honoraria and unrestricted educational grants from Abbott, Novodisk, Eli Lilly, Medtronic, Insulet and Dexcom. Emma G. Wilmot has received personal fees from Abbott Diabetes Care, Dexcom, Eli Lilly, Insulet, Medtronic, Novo Nordisk, Sanofi Aventis. Peter Hammond has received personal fees from Abbott Diabetes Care, Dexcom, Eli Lilly, Insulet, Medtronic, Novo Nordisk, Sanofi Aventis, Glooko/Diasend. Sze M. Ng has nothing to disclose. A McLay is a user of artificial pancreas systems and has received personal fees from Eli Lilly and Novo Nordisk. The need for ethical approval for this questionnaire was assessed by the MRC online tool and was deemed not to require it. The Association of British Clinical Diabetologist's Diabetes Technology Network committee approved the study. Survey participation was entirely voluntary; therefore completion was deemed to be consent to participate. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
month = feb,
doi = "10.1007/s13300-022-01203-5",
language = "English",
volume = "13",
pages = "341--353",
journal = "Diabetes Therapy",
issn = "1869-6953",
publisher = "Springer Publishing Company",
number = "2",
}
